6 -benzylphenyl2 - sulfurterahydropyran-3, 4, 5 -triol derivatives as inhibitors of sodium -glucose cotrans porters 1 and 2 for use in diabetic patients

Details for Australian Patent Application No. 2011223861 (hide)

Owner Lexicon Pharmaceuticals, Inc.

Inventors Brown, Philip Manton; Freiman, Joel Philip; Powell, David Reed

Agent Pizzeys

Pub. Number AU-A-2011223861

PCT Pub. Number WO2011/109333

Priority 61/309,592 02.03.10 US

Filing date 1 March 2011

Wipo publication date 9 September 2011

International Classifications

A61K 31/351 - not condensed with another ring

A61P 9/00 Drugs for disorders of the cardiovascular system

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/109333 Priority application(s): WO2011/109333

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223866-Methods and compositions for treating Degos' disease

2011223835-Compositions and methods for increasing biomass, iron concentration, and tolerance to pathogens in plants